Sweden-based biotics solutions company Probi, a subsidiary of German chemicals company Symrise AG (ETR: SY1), announced on Wednesday that it has expanded its portfolio with two new categories: Sports & Active Nutrition by Probi and Pets by Probi.

The company said the launches advance its strategy to deliver clinically documented biotic solutions that support health for both humans and animals.

Probi noted rising demand for natural, science-based products in active nutrition, citing a 15.4% increase in US performance nutrition sales in 2024 and stronger global supplement usage.

Sports & Active Nutrition by Probi is built around the probiotic strain L. plantarum 299V, developed to support cardio-respiratory function, digestive comfort during exercise, circulatory health, endurance and vitality.

Probi is also entering the pet supplement market with two probiotic solutions for dogs and cats, targeting digestive health and oral health. The Pets by Probi range features the strain L. plantarum 6595 for digestive support and S. salivarius BLIS K12 and BLIS M18 for oral care, supported by a revised agreement granting Probi exclusive distribution rights for the BLIS strains in selected markets.

The company added that it has secured National Animal Supplement Council Preferred Supplier certification in the United States, reflecting its focus on quality and safety in companion animal health.